Abstract: A compound having the formula: is useful in the preparation of compounds of Formula I.

Abstract: Disclosed are techniques for hosting a communication session in a call server between communication devices. The call server functions as a bridge service between the communication devices joining an original communication link between the first communication device and the call server with a second communication link between the second communication device and the call server. The first communication device includes at least two RF transceivers each capable of communicating with the call server over a separate network. The call server receives a signal from the first communication device indicative of the need to handoff the original communication link to an alternate communication link on an alternate network. The call server establishes the alternate communication link with the first communication device on the alternate network and joins it with the second communication link to maintain the communication session between the communication devices.

Abstract: A compound having the formula: is useful in the preparation of compounds of Formula I.

Abstract: Compounds of Formula (I): in which A1, A2, W, L, G, R7a, R7b, R8, R9 and R10 have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.

Abstract: Compounds of formula (I): in which R1, R2, R7, R8, R9, R10 and A have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.

Abstract: The system contains a substrate having at least one electrical trace formed thereon. An opening is formed in the substrate. The opening comprising at least one wall. An electrically conductive fill is formed in the opening. The electrically conductive fill is chemically bonded to the wall and electrically contacted with the electrical trace.

Abstract: Compounds of formula (I): in which R1, R2, R7, R8, R9, R10 and A have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.

Abstract: The invention provides novel tricyclic compounds of Formula I? that inhibit ?-secretase cleavage of APP and are useful as therapeutic agents for treating neurodegenerative diseases.

Abstract: Compounds of Formula (I): in which R1, R2, R7, R8, R9, R10 and A have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.

Abstract: Compounds of Formula I: (I) in which A, A1, R1, R7a, R7b, R8 and R10 have the meanings given in the specification, are DP2 receptor inhibitors useful in the treatment of useful in the treatment and prevention of immunologic diseases, allergic diseases such as asthma, allergic rhinitis and atopic dermatitis, and other inflammatory diseases mediated by prostaglandin D2 (PGD2). The compounds of Formula I may also be useful in treating diseases or medical conditions involving the Th2 T cell via production of IL-4, IL-5 and/or IL-13.

Abstract: The invention provides novel spirotetrahydronaphthalene compounds of Formula ? that inhibit ?-secretase cleavage of APP and are useful as therapeutic agents for treating neurodegenerative diseases.

Abstract: Compounds of Formula (I): in which A1, A2, W, L, G, R7a, R7b, R8, R9 and R10 have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.

Abstract: The system contains a substrate having at least one electrical trace formed thereon. An opening is formed in the substrate. The opening comprising at least one wall. An electrically conductive fill is formed in the opening. The electrically conductive fill is chemically bonded to the wall and electrically contacted with the electrical trace.

Abstract: Compounds of Formula (I): in which R1, R2, R7, R8, R9, R10 and A have the meanings given in the specification, are DP2 receptor modulators useful in the treatment of immunologic diseases.

Abstract: Aryl- and heteroaryl-substituted urea compounds useful in the treatment of diseases and conditions related to DNA damage or lesions in DNA replication are disclosed. Methods of making the compounds, and their use as therapeutic agents, for example, in treating cancer and other diseases characterized by defects in DNA replication, chromosome segregation, or cell division also are disclosed.

Abstract: Provided is a manually operated wash station that can simultaneously apply a wash process to multiple cells of a multi-well synthesis reactor plate. Further provided is a manually operated wash station that can be adapted to automatic computer control. A method for simultaneously washing a plurality of wells in a multi-well container is provided. Additionally, a method for purifying a plurality of chemical products simultaneously in a multi-well reactor plate.

Abstract: A clamping system including a cover plate with an underside having at least one step, and a bottom plate having a base connected to a first side, a second side, a third side, and a fourth side. The bottom plate also has a well for receiving a reactor plate. The clamping system further includes a compression skirt positioned between the cover plate and the bottom plate, with the compression skirt having a first side, a second side, a third side, and a fourth side corresponding to the first, second, third, and fourth sides of the bottom plate, respectively. Additionally, the clamping system includes a first and a second upper latch assembly for clamping the cover plate to the compression skirt, and a first and a second lower latch assembly for clamping the compression skirt to the bottom plate.